Hepatitis Research Review, Issue 34

In this Issue:

Benefits of HCV cure in established cirrhosis
Statins protect against cirrhosis and HCC in chronic HCV
Continue HCC surveillance after HCV cure
Sofosbuvir/velpatasvir: subjective improvement in ASTRAL-1
Full-dose sofosbuvir for haemodialysis patients with HCV?
HBV core-related antigen may predict HCC development
Cirrhosis: no impact on intra-hepatic innate immunity during DAAT
HCV and B-cell NHL: evidence of a causal association
The natural history of HEV infection in immunocompetent patients
HEV tropism is not restricted to the liver

Please login below to download this issue (PDF)

Subscribe